Topics

Articles

The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.




Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Jasmin Patel of a-Connect provides insight on how to navigate the ebbs and flows of employment. 




Expansion expected to help tackle health issues at a faster rate, company says




Annual report finds continuing impact of COVID-19 on global markets

Partnership aims to lower prescription drug costs and increase price transparency

Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio 

A Q&A with AstraZeneca’s Country President for Belgium & Luxembourg, Keira Driansky

Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech

Purchase strengthens Amgen’s therapeutics portfolio